Daniel J Drucker

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Ankylosing Spondylitis

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Circulation research

Nature reviews. Endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel J Drucker
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity. Diabetes care (2024)
Chen Gao, Zhaojun Xiong, Yunxia Liu, Meng Wang, Menglong Wang, Tian Liu, Jianfang Liu, Shuxun Ren, Nancy Cao, Hai Yan, Daniel J Drucker, Christoph Daniel Rau, Tomohiro Yokota, Jijun Huang, Yibin Wang
Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction. Circulation research 135 (5) (2024)
Chen Gao, Zhaojun Xiong, Yunxia Liu, Meng Wang, Menglong Wang, Tian Liu, Jianfang Liu, Shuxun Ren, Nancy Cao, Hai Yan, Daniel J Drucker, Christoph Daniel Rau, Tomohiro Yokota, Jijun Huang, Yibin Wang
Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction. Circulation research (2024)
Chen Gao, Zhaojun Xiong, Yunxia Liu, Meng Wang, Menglong Wang, Tian Liu, Jianfang Liu, Shuxun Ren, Nancy Cao, Hai Yan, Daniel J Drucker, Christoph Daniel Rau, Tomohiro Yokota, Jijun Huang, Yibin Wang
Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction. Circulation research 135 (5) (2024)
Keita Ochiai, Asuka Muto, Bong Soo Seok, Yuta Doi, Yusaku Iwasaki, Yuko Okamatsu-Ogura, Daniel J Drucker, Tohru Hira
Glucagon-like peptide-1 is involved in the thermic effects of dietary proteins in male rodents. Endocrinology (2023)
Daniel J Drucker, Jens Juul Holst
The expanding incretin universe: from basic biology to clinical translation. Diabetologia (2023)
John R Ussher, Daniel J Drucker
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nature reviews. Cardiology (2023)
Andrew R Castle, Sang-Gyun Kang, Ghazaleh Eskandari-Sedighi, Serene Wohlgemuth, My-Anh Nguyen, Daniel J Drucker, Erin E Mulvihill, David Westaway
Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Jonathan E Campbell, Jacqueline L Beaudry, Berit Svendsen, Laurie L Baggio, Andrew N Gordon, John R Ussher, Chi Kin Wong, Fiona M Gribble, David A D'Alessio, Frank Reimann, Daniel J Drucker
GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue. Diabetes 71 (5) (2022)
Rola Hammoud, Daniel J Drucker
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1. Nature reviews. Endocrinology 19 (4) (2022)
Andrew R Castle, Sang-Gyun Kang, Ghazaleh Eskandari-Sedighi, Serene Wohlgemuth, My-Anh Nguyen, Daniel J Drucker, Erin E Mulvihill, David Westaway
Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Andrew R Castle, Sang-Gyun Kang, Ghazaleh Eskandari-Sedighi, Serene Wohlgemuth, My-Anh Nguyen, Daniel J Drucker, Erin E Mulvihill, David Westaway
Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Rola Hammoud, Daniel J Drucker
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1. Nature reviews. Endocrinology (2022)
Andrew R Castle, Sang-Gyun Kang, Ghazaleh Eskandari-Sedighi, Serene Wohlgemuth, My-Anh Nguyen, Daniel J Drucker, Erin E Mulvihill, David Westaway
Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Rola Hammoud, Daniel J Drucker
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1. Nature reviews. Endocrinology 19 (4) (2022)
Andrew R Castle, Sang-Gyun Kang, Ghazaleh Eskandari-Sedighi, Serene Wohlgemuth, My-Anh Nguyen, Daniel J Drucker, Erin E Mulvihill, David Westaway
Beta-endoproteolysis of the cellular prion protein by dipeptidyl peptidase-4 and fibroblast activation protein. Proceedings of the National Academy of Sciences of the United States of America 120 (1) (2022)
Carmelo Quarta, Kerstin Stemmer, Aaron Novikoff, Bin Yang, Felix Klingelhuber, Alex Harger, Mostafa Bakhti, Aimee Bastidas-Ponce, Eric Baugé, Jonathan E Campbell, Megan Capozzi, Christoffer Clemmensen, Gustav Collden, Perla Cota, Jon Douros, Daniel J Drucker, Barent DuBois, Annette Feuchtinger, Cristina García-Cáceres, Gerald Grandl, Nathalie Hennuyer, Stephan Herzig, Susanna M Hofmann, Patrick J Knerr, Konxhe Kulaj, Fanny Lalloyer, Heiko Lickert, Arkadiusz Liskiewicz, Daniela Liskiewicz, Gandhari Maity, Diego Perez-Tilve, Sneha Prakash, Miguel A Sanchez-Garrido, Qian Zhang, Bart Staels, Natalie Krahmer, Richard D DiMarchi, Matthias H Tschöp, Brian Finan, Timo Dirk Müller
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice. Nature metabolism 4 (8) (2022)
Daniel J Drucker
Transforming type 1 diabetes: the next wave of innovation. Diabetologia 64 (5) (2021)
Laurie L Baggio, Elodie M Varin, Jacqueline A Koehler, Xiemin Cao, Yuliya Lokhnygina, Susanna R Stevens, Rury R Holman, Daniel J Drucker
Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans. Nature communications 11 (1) (2020)
Mari Lilith Lund, Giovanni Sorrentino, Kristoffer Lihme Egerod, Chantal Kroone, Brynjulf Mortensen, Filip K Krag Knop, Frank Reimann, Fiona M Gribble, Daniel J Drucker, Eelco J P de Koning, Kristina Schoonjans, Fredrik Bäckhed, Thue W Schwartz, Natalia Petersen
L-Cell Differentiation Is Induced by Bile Acids Through GPBAR1 and Paracrine GLP-1 and Serotonin Signaling. Diabetes 69 (4) (2020)
Daniel J Drucker
Advances in oral peptide therapeutics. Nature reviews. Drug discovery 19 (4) (2019)
Teayoun Kim, Shelly Nason, Cassie Holleman, Mark Pepin, Landon Wilson, Taylor F Berryhill, Adam R Wende, Chad Steele, Martin E Young, Stephen Barnes, Daniel J Drucker, Brian Finan, Richard DiMarchi, Diego Perez-Tilve, Matthias Tschöp, Kirk M Habegger
Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21. Diabetes 67 (9) (2018)
Daniel J Drucker
The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications. Diabetes 67 (9) (2018)
Friederike Remm, Nicolle Kränkel, Daniela Lener, Daniel J Drucker, Sieghart Sopper, Christoph Brenner
Sitagliptin Accelerates Endothelial Regeneration after Vascular Injury Independent from GLP1 Receptor Signaling. Stem cells international 2018 (2018)
Teayoun Kim, Cassie L Holleman, Shelly Nason, Deanna M Arble, Nickki Ottaway, Joseph Chabenne, Christine Loyd, Jeong-A Kim, Darleen Sandoval, Daniel J Drucker, Richard DiMarchi, Diego Perez-Tilve, Kirk M Habegger
Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents. Diabetes 67 (11) (2018)
Brandon L Panaro, Grace B Flock, Jonathan E Campbell, Jacqueline L Beaudry, Xiemin Cao, Daniel J Drucker
β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation. Diabetes 66 (6) (2017)
Julie A Lovshin, Harindra Rajasekeran, Yulyia Lytvyn, Leif E Lovblom, Shajiha Khan, Robel Alemu, Amy Locke, Vesta Lai, Huaibing He, Lucinda Hittle, Weixun Wang, Daniel J Drucker, David Z I Cherney
Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α1-67 in Patients With Type 2 Diabetes. Diabetes care 40 (8) (2017)